HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
PANW
Palo Alto Networks, Inc.
PANW's fundamentals are mixed, but it looks expensive: trading at 807x earnings, about seven times its usual 119x. Its downside scenario is about six times its upside.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
PANW Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Strong | |
| Strong |
PANW's revenue, cash flow and balance sheet are currently strong, and its profitability is stable.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
PANW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 48x | $19.37 | -94% |
| Forward | 74x | $323 | — |
| Fair | 117x | $46.90 | -85% |
| Expensive | 344x | $138 | -57% |
| Current | 807x | $323 | — |
Historical ranges are pointers, not guarantees.
PANW's PE is in its expensive range at 807x. If earnings grow as analysts expect, today's price would be 74x next year's earnings, in its cheap range.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
PANW Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Strong growth | |
| Weakening | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for PANW, but weaker profitability.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
PANW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.34 | +985% |
| Q3 2026 | $0.40 | -75% |
| Q2 2026 | $1.21 | -32% |
| Q1 2026 | $1.80 | +0.6% |
| Q4 2025 | $1.57 | -59% |
| Q3 2025 | $1.60 | -56% |
| Q2 2025 | $1.77 | -49% |
| Q1 2025 | $1.79 | -44% |
| Q4 2024 | $3.85 | +333% |
PANW has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over PANW on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
PANW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.4B | +34% |
| Q2 2026 | $3B | +31% |
| Q1 2026 | $2.6B | +15% |
| Q4 2025 | $2.5B | +16% |
| Q3 2025 | $2.5B | +16% |
| Q2 2025 | $2.3B | +15% |
| Q1 2025 | $2.3B | +14% |
| Q4 2024 | $2.1B | +14% |
PANW's revenue has grown year over year every quarter since late 2020: $3.4B last quarter, up 34% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5% | -15 points |
| Q2 2026 | -6.1% | -16 points |
| Q1 2026 | 15% | +4.7 points |
| Q4 2025 | 12% | -0.9 points |
| Q3 2025 | 20% | +8.7 points |
| Q2 2025 | 9.6% | +0.7 points |
| Q1 2025 | 11% | +7.9 points |
| Q4 2024 | 13% | +1.9 points |
PANW has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over PANW on cash flow, with more consistent year-over-year improvement.
PANW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.3B | +34% |
| Q2 2026 | $788M | +41% |
| Q1 2026 | $384M | -25% |
| Q4 2025 | $1.7B | +15% |
| Q3 2025 | $934.5M | +101% |
| Q2 2025 | $560.4M | +14% |
| Q1 2025 | $509.4M | -22% |
| Q4 2024 | $1.5B | -1.6% |
PANW's free cash flow has been positive every quarter for seven years: $4.1B over the past year, up 19% from the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over PANW on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
PANW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -4.6% | -37M shares |
| 1 year | +7.7% | +54.7M shares |
| 3 years | +12% | +79.4M shares |
| 5 years | +32% | +186M shares |
| Available history | +32% | +184M shares |
PANW has 764M diluted shares, up 7.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $500M |
| Q1 2024 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
PANW Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.6x | Net Cash |
| Q2 2026 | -1.5x | Net Cash |
| Q1 2026 | -2.3x | Net Cash |
| Q4 2025 | -1.9x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -2.2x | Net Cash |
PANW has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
PANW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.6 | Neutral |
| Stochastic | 18.8 | Oversold |
PANW's weekly RSI is 50 (neutral) and its Stochastic is 19 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
PANW PE vs Technology Sector
| Metric | PANW | Sector median | Relative |
|---|---|---|---|
| PE | 807x | 28x | 2,795% above |
| PE % | 89 | 35 | 54 pts above |
PANW is trading at 807x earnings, a 2795% premium to the Technology sector's median of 28x.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
PANW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $365.2 | 12% below |
| 20 week MA | $355.8 | 9.3% below |
| 50 week MA | $260.9 | 24% above |
| 100 week MA | $225.6 | 43% above |
| 200 week MA | $182.3 | 77% above |
PANW has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
PANW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $38.9 | $61.2 | +57% |
| 2021 | $61.2 | $93.6 | +53% |
| 2022 | $93.6 | $70.6 | -25% |
| 2023 | $70.6 | $147.4 | +109% |
| 2024 | $147.4 | $186.2 | +26% |
| 2025 | $186.2 | $188.5 | +1.2% |
| 2026 YTD | $188.5 | $322.7 | +71% |
PANW has the edge over HIMS on returns for 2026, with the stronger performance.